ACR 0.00% 6.7¢ acrux limited

Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-77

  1. 1,338 Posts.
    lightbulb Created with Sketch. 58
    Sure. But can someone please point out the issue here.

    I want technical detail and facts please.

    So the patent for underarm administration has been squashed.. but the patent for delivery via skin on the other parts of the body was still ruled ok? (but expires shortly anyway)

    Is that the crux of it? (pun intended)

    It's all skin. Right? whether it's underarm or on your belly, back or anywhere...

    So can someone please explain me the technicalities.....

    What is the big deal with this ruling?

    Why can't the product simply just be "rolled on" by the applicator somewhere else?
    Last edited by jaygatsby: 24/08/16
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.